AZD1390
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AZD1390, covering 2018-02-26 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma [Phase 1]